Addus HomeCare Corporation logo

Addus HomeCare Corporation(ADUS)

upturn advisory logo
EXPLORE ADVISORIES AND THEIR HISTORY
QUALITY SIGNAL RECENCY
2-STAR RATING
Consider higher Upturn Star rating
BUY for 22 days
PROFIT SINCE LAST BUY
-0.14% ▼
LAST CLOSE
$122.5
11/20/2026
(24-hour delay)

Advisory History & Simulated Performance *

*as per simulation (see disclosures)
  • ALL
  • 1Y
  • 1M
  • 1W
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • PASS (Skip)
Upturn Stock price based on last close iconStock price based on last close
Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Advisory Performance History (Simulated)Advisory Performance History info

Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Upturn Advisory & Investor View for ADUS

11/20/2026: ADUS (2-star) has a low Upturn Star Rating. Not recommended to BUY.

Addus HomeCare Corporation is a prominent U.S. provider of home-based personal care, hospice, and skilled nursing services tailored for elderly and chronically ill individuals. The company's core strength lies in its reliable personal care segment, which yields steady recurring revenue backed by favorable demographic aging trends. Its primary growth strategy centers on expanding geographic density through targeted tuck-in acquisitions. However, the business remains vulnerable to state Medicaid reimbursement pressures and labor wage constraints. The stock is well-suited for growth-oriented investors willing to monitor regulatory updates and state-level funding developments.

How to Read the Upturn Advisory

The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.

Company fundamentals, valuation, risks, and news provide supporting context about the business.

Investor Fit

Investor styleFitWhy
Growth investorStrong fitAddus offers consistent revenue expansion fueled by favorable long-term demographic trends and strategic tuck-in acquisitions.
Momentum investorMixed fitThe stock can experience periods of strong relative performance, though momentum is conditional on favorable sector sentiment and positive earnings revisions.
Value investorStrong fit while signal remains positiveThe stock trades at a reasonable forward valuation multiple relative to its earnings growth potential compared to other healthcare peers.
Dividend investorWeak fitThe company does not pay dividends, prioritizing capital reinvestment for business expansion instead.
Low-risk investorMixed fitWhile healthcare demand is defensive, regulatory exposure to state Medicaid policies introduces policy-related volatility.

Risk Profile

Risk factorLevelWhy it matters
Price volatilityMediumThe stock experiences moderate price swings driven by broader healthcare sector rotations and regulatory headlines.
Valuation riskLowReasonable earnings multiples limit downside valuation risk under normal operating conditions.
Competition risk (payer and labor competition)MediumIntense competition for direct-care workers and nurse staffing can pressure operating margins and wage expenses.
Business qualityStrongThe company features a resilient asset-light business model with steady cash conversion.
Dividend incomeLow / noneIncome-focused investors receive no dividend distributions from the stock.
Execution riskMediumSuccessful integration of recent acquisitions and effective navigation of state reimbursement changes are vital for sustained profitability.

Key Highlights

Company Size Mid-Cap Stock
Market Capitalization 2.28B USD
Price to earnings Ratio 20.38
1Y Target Price 141.46
Price to earnings Ratio 20.38
1Y Target Price 141.46
Volume (30-day avg) 237.7K shares
Beta 0.74
52 Weeks Range 87.95 - 131.59
Updated Date 11/20/2026
52 Weeks Range 87.95 - 131.59
Updated Date 11/20/2026
Dividends yield (FY) -
Basic EPS (TTM) 6.01

Sector & Industry Intelligence

Sector

Healthcare

Constructive
Sentiment
Strong Bullish
Momentum
BUY Breadth Improving
BUY participation
55.2%
Active BUY / eligible
53 / 96
30-Day BUY Count Change
+19
Market state
Strong Bullish

More qualifying stocks are receiving or maintaining BUY advisories, indicating improving market participation.

Industry

Medical Care Facilities

BUY participation
85.7%
Active BUY / eligible
6 / 7
30-Day BUY Count Change
+2

Sector signal summarizes BUY breadth conditions for the sector. It does not override this stock’s BUY, SELL, or PASS advisory.

Price Behavior

Strong Uptrend
PRICE PATH

Strong Uptrend

The stock has maintained a strong upward price trend across the last three quarters.

Smooth
PRICE STABILITY

Smooth

The stock has moved along a generally orderly path with only modest fluctuations.

Analysis of Past Performance

Type Stock
Historic Profit 6.99%
Avg. Invested days 38
Today’s Advisory Consider higher Upturn Star rating
Upturn Advisory Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 3.0
Stock Returns Performance Upturn Returns Performance icon 2.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 11/20/2026

Upturn Scorecard

Upturn Star Rating

★★★★★
ADUS receives a 3-star rating, supported by solid company fundamentals, and solid analyst coverage. The rating is constrained by weak price momentum.

Company Fundamentals

★★★★★
ADUS has solid overall fundamentals (4 stars), with moderate financial health, solid growth momentum, and solid ownership. In FY2025 versus FY2024, solid earnings growth (+30.3%) and solid cash generation (FCF margin 7.3%) are partially offset by soft profitability (net margin 6.7%), modest insider ownership of 2.72%.

Financial Health Rating

★★★★★
ADUS's financial health is supported by solid cash strength, including free-cash-flow generation (7.3% of revenue). Profitability is moderate (3 stars), which helps explain the 3-star overall score.

Growth Momentum Score

★★★★★
Earnings growth is ADUS's strongest growth driver at +30.3% FY2025 versus FY2024 (solid, 4 stars). By comparison, revenue growth (+23.2%, solid) is also solid, while free-cash-flow growth (-6.0%, negative) holds the profile back, so recent growth is not broad-based across the business.

Ownership

★★★★★
Institutional ownership is 108.7% and approximately 95.1% of outstanding shares are publicly tradable, supporting liquidity and institutional participation. Insider ownership of 2.72% provides only moderate management-shareholder alignment.

Top 5 Institutional Investors

BlackRock Inc 18.38%
Capital Research Global Investors 7.45%
Dimensional Fund Advisors, Inc. 4.92%
Vanguard Capital Management, LLC 4.24%
State Street Corp 4.17%

Unit Economics (Per $1K Revenue)

★★★★★
ADUS generates approximately $325 of gross profit, $97 of operating income, and $73 of free cash flow for every $1,000 of revenue. Based on FY2025 results. Soft margins and solid cash conversion support a 3-star rating, while capital efficiency is soft.

Economic Dimensions

★★★★★
Effective Tax Rate: 24.74%

Quantitative Style Profile

★★★★★
ADUS has a liquid, relatively low-volatility profile. Weak momentum is the primary drawback.

Style Classification

Quality Focused

Value-OrientedLow VolatilitySmall / Mid Cap RiskShort Squeeze RiskHighly Liquid / Institution-Friendly

How Company Makes Money

Business areaWhat it includesRetail investor read
Personal CareNon-medical assistance with daily activities for elderly and disabled individuals, largely funded through state Medicaid programs.This is the primary revenue engine of the company, providing stable, recurring cash flows.
Hospice CarePalliative and end-of-life care services compensated primarily via Medicare per-diem reimbursements.Offers higher margins and serves as a key complementary service line within the care continuum.
Home HealthSkilled nursing and physical therapy services provided after acute hospitalizations.Represents a smaller segment that adds clinical breadth to the company's service offerings.

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Earnings Date

Report Date 2026-11-03
When After Market
Estimate 1.61
Actual 1.71

Profitability

Profit Margin 7.39%
Operating Margin (TTM) 10.41%

Management Effectiveness

Return on Assets (TTM) 6.8%
Return on Equity (TTM) 9.96%

Valuation

Trailing PE 20.38
Forward PE 15.9
Enterprise Value 2.22B
Price to Sales(TTM) 1.52
Enterprise Value 2.22B
Price to Sales(TTM) 1.52
Enterprise Value to Revenue 1.48
Enterprise Value to EBITDA 12.8
Shares Outstanding 18.63M
Shares Floating 17.73M
Shares Outstanding 18.63M
Shares Floating 17.73M
Percent Insiders 2.72
Percent Institutions 108.71

Financial Metrics

🧭 Investment Snapshot

Total Revenue (Scale)

Information icon Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.

Net Income (Profit)

Information icon Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.

Free Cash Flow (Cash Strength)

Information icon Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.

📈 Growth & Strength

Operating Income (Core Profit)

Information icon Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.

EBITDA (Cash Earnings)

Information icon Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.

Gross Profit (Unit Profitability)

Information icon Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.

🛡️ Financial Safety

Cash (Liquidity Buffer)

Information icon Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.

Total Debt (Leverage Risk)

Information icon Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.

Net Working Capital (Short-Term Health)

Information icon Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.

🧱 Balance Sheet Strength

Stockholder Equity (Net Worth)

Information icon Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.

Total Assets (Asset Base)

Information icon The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.

Income Before Tax (Pre-Tax Earnings)

Information icon Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.

⚙️ Cost & Drag Factors

Cost of Revenue (Production Cost)

Information icon Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.

Total Operating Expenses (Operating Cost)

Information icon Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.

Income Tax Expense (Tax Drag)

Information icon Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Form CRS provides a relationship summary of our automated advisory services, flat subscription fees, and conflicts of interest. Form ADV Part 2A brochure contains complete details on services, billing, and disclosures. If any summary differs from our current regulatory filings, the filed Form ADV controls.